Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting.
Authorsvan Zyl, Gert Uves
van Mens, Thijs E
Nachega, Jean B
van der Merwe, Lize
AffiliationDivision of Medical Virology, Department of Pathology, NHLS Tygerberg and Stellenbosch University, Tygerberg, South Africa. email@example.com
MetadataShow full item record
AbstractIn resource-limited settings, many patients, with no prior protease inhibitor (PI) treatment on a second-line, high genetic barrier, ritonavir-boosted PI-containing regimen have virologic failure.
- Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study.
- Authors: La Rosa AM, Harrison LJ, Taiwo B, Wallis CL, Zheng L, Kim P, Kumarasamy N, Hosseinipour MC, Jarocki B, Mellors JW, Collier AC, ACTG A5273 Study Group.
- Issue date: 2016 Jun
- Random lopinavir concentrations predict resistance on lopinavir-based antiretroviral therapy.
- Authors: Court R, Gordon M, Cohen K, Stewart A, Gosnell B, Wiesner L, Maartens G
- Issue date: 2016 Aug
- Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.
- Authors: Walmsley S, Bernstein B, King M, Arribas J, Beall G, Ruane P, Johnson M, Johnson D, Lalonde R, Japour A, Brun S, Sun E, M98-863 Study Team.
- Issue date: 2002 Jun 27
- Lopinavir/ritonavir: a review of its use in the management of HIV infection.
- Authors: Cvetkovic RS, Goa KL
- Issue date: 2003
- It is time to consider third-line options in antiretroviral-experienced paediatric patients?
- Authors: Zyl GU, Rabie H, Nuttall JJ, Cotton MF
- Issue date: 2011 Nov 15